Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)
Department of Health and Human Services ▸ National Institutes of Health
Description
Purpose: Funds investigator-initiated, milestone-driven clinical trials that test regenerative medicine therapies in people. The goal is to accelerate safe, rigorous evaluation of innovative cell, gene, and tissue-based interventions.
Mechanism: UH3 cooperative agreement. This means an interventional clinical trial is required and NIH program staff will be actively involved in oversight and milestones.
What can be studied:
Stem cell–ba…
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Required)
Source
Grant ID
RFA-AR-25-014
Funding Source
Department of Health and Human Services ▸ National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- Private institutions of higher education
- Small businesses
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- State governments
- City or township governments
- For profit organizations other than small businesses
- Public housing authorities/Indian housing authorities
- Native American tribal governments (Federally recognized)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Public and State controlled institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Special district governments
- County governments
- Independent school districts
Links
Documents
Similar opportunities
- Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)
- Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
- Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
- Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)
- Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)